You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Randomized Prospective Phase II Clinical Trial of NVX-108 in Association with Chemoradiation of Glioblastoma
SBC: NUVOX PHARMA, L.L.C. Topic: 102Glioblastoma multiforme (GBM) is a malignant primary brain tumor affecting about 12,000 new cases per year in the U.S. Average survival is only about 14-15 months. Radiation (RT) is most commonly administered as 30 fractions of 2 Gray each over 6-weeks with concomitant temozolomide (TMZ). GBM tumors are hypoxic. The primary mechanism of RT is creation of singlet oxygen; hypoxia within GBM adversel ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
An Integrated Microarray Printing and Detection System
SBC: BIOSENSING INSTRUMENT INC Topic: 400DESCRIPTIONprovided by applicantMicroarray technology has dramatically advanced the study of protein interactions leading to discovery and validation of new biomarkers and therapeutic drugsTypicallyprotein microarrays are pre spotted with target molecules in one device and then tested with probe molecules using another deviceDuring each testing cyclethe entire microarray becomes exposed to the pro ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
STTR Phase I: Silicon nanowire arrays for the sensitive detection and identification of lung cancer by a blood sample
SBC: ADVANCED SILICON GROUP, INC. Topic: SThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is the possibility to revolutionize the treatment of cancer through more sensitive and specific cancer biomarker detection. 1.66 million Americans were diagnosed with cancer in 2014 alone, of which 585,720 died. The sum of all health care costs in 2011 for cancer in the US was $88.7 billion. ...
STTR Phase I 2017 National Science Foundation -
STTR Phase I: Novel Radar Using 3D Printed Luneburg Lens for Autonomous Transportation
SBC: LUNEWAVE INC. Topic: EWThe broader impact/commercial potential of this project is significant. The research results will address the resolution and detection speed requirements of autonomous driving in complex environments such as urban scenarios. The next major revolution of transportation is undoubtedly autonomous driving which will bring great potential benefits in terms of safety, mobility and related productivity. ...
STTR Phase I 2017 National Science Foundation -
SBIR Phase I: Affordable On-Demand Additive Manufacturing
SBC: ThinkIncubate Topic: MNThis SBIR Phase I project will develop a proof-of-concept for a new approach in the field of Additive Manufacturing (AM). Pioneered few decades ago, AM has the potential to enable the manufacture of products from the inside out, enabling the production of lighter products with higher structural integrity than is possible with conventional subtractive manufacturing techniques. However, legacy AM ap ...
SBIR Phase I 2017 National Science Foundation -
SBIR Phase I: Development of an electrochemical C-C bond forming reaction
SBC: Snapdragon Chemistry, Inc. Topic: CTThis SBIR Phase I project is proposing the development of a new electrochemical method for the manufacture of chemicals of interest to pharmaceutical, agricultural and fine chemical producers. New chemical manufacturing technologies are needed to reduce the environmental costs and the risk posed by traditional chemical manufacturing technologies. Flow technology is reducing the hazard, environment ...
SBIR Phase I 2017 National Science Foundation -
SBIR Phase I: High multiplex visual mapping of heterogeneity in FFPE biospecimen
SBC: BIOSYNTAGMA, LLC Topic: BMThis SBIR Phase I project will address drug resistance in cancer patients through the advanced analysis of biopsies. Not only is each patient unique but their tumor contains a high level of genetic diversity as well. Overlooked diversity within patient tumors can lead to inadequate treatment and consequently acquired drug resistance, and has also been shown to predict therapeutic response to certa ...
SBIR Phase I 2017 National Science Foundation -
SBIR Phase I: Agile Model Reduction for Topology Optimization Software
SBC: NEWGRID, INC Topic: EWThe broader impact/commercial potential of this project is a substantial increase in the efficiency and reliability of the power grid, which would result in lower electricity rates to consumers and facilitate the integration of renewable energy into the grid. This project will enable the use of topology optimization in the operation of the power transmission grid and allow operators to adapt the g ...
SBIR Phase I 2017 National Science Foundation -
SBIR Phase I: Closed-Loop Lithium Reduction of Pure Scandium Metal
SBC: INFINIUM, INC. Topic: MNThe broader impact/commercial potential of this Small Business Innovation Research Phase I project is to reduce the cost, and improve commercialization prospects, for new light-weight scandium-containing alloys with extraordinary strength, weldability, fitness for 3-D printing, and new shape memory and other properties. At $3500-4000/kg (6-7 times the price of silver), the price of scandium metal ...
SBIR Phase I 2017 National Science Foundation -
SBIR Phase I: Programmable Intracellular Sensors for Direct In Vivo Screening of Target Molecule Production in Yeast
SBC: ENEVOLV, INC. Topic: BTThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to develop a tool to allow for more rapid screening of engineered yeast strains for the production of desirable biochemical compounds. Industries such as specialty chemicals, food, energy, personal care, and pharmaceuticals are increasingly using engineered microorganisms, especially yeast, for bio ...
SBIR Phase I 2017 National Science Foundation